TY - JOUR
T1 - Infusion Therapy in the Treatment of Neuropathic Pain
AU - McMullin, Preston R.
AU - Hynes, Alexander Thomas
AU - Arefin, Mohammed Ahnaf
AU - Saeed, Moawiz
AU - Gandhavadi, Sarvani
AU - Arefin, Nuha
AU - Eckmann, Maxim S.
N1 - Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2022/9
Y1 - 2022/9
N2 - Purpose of Review: Neuropathic pain is a prevalent and burdensome condition. While oral medical therapies are the first-line treatment for refractory neuropathic pain, in some cases, infusion therapy may be employed. This article is a systematic review of recent publications regarding epidemiologic, pathophysiologic, diagnostic, and therapeutic advancements in the treatment of neuropathic pain using intravenous infusion therapy. Special consideration will be given to relevant and practically used agents and available information on outcomes. Recent Findings: Individuals with neuropathic pain from various etiologies (e.g. trigeminal neuralgia, post-herpetic neuralgia, diabetic neuropathy) often find short-term relief from infusion therapies. However, it is difficult to generalize the findings of these studies to form a standard treatment regimen. Summary: The purpose of this paper is to provide clinicians an up-to-date summary of recent literature regarding several infusion therapies in treating neuropathic pain.
AB - Purpose of Review: Neuropathic pain is a prevalent and burdensome condition. While oral medical therapies are the first-line treatment for refractory neuropathic pain, in some cases, infusion therapy may be employed. This article is a systematic review of recent publications regarding epidemiologic, pathophysiologic, diagnostic, and therapeutic advancements in the treatment of neuropathic pain using intravenous infusion therapy. Special consideration will be given to relevant and practically used agents and available information on outcomes. Recent Findings: Individuals with neuropathic pain from various etiologies (e.g. trigeminal neuralgia, post-herpetic neuralgia, diabetic neuropathy) often find short-term relief from infusion therapies. However, it is difficult to generalize the findings of these studies to form a standard treatment regimen. Summary: The purpose of this paper is to provide clinicians an up-to-date summary of recent literature regarding several infusion therapies in treating neuropathic pain.
KW - Infusion therapy
KW - Ketamine
KW - Lidocaine
KW - Magnesium
KW - Neuropathy
KW - Vitamin B12
UR - http://www.scopus.com/inward/record.url?scp=85133586573&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85133586573&partnerID=8YFLogxK
U2 - 10.1007/s11916-022-01071-5
DO - 10.1007/s11916-022-01071-5
M3 - Review article
C2 - 35794449
AN - SCOPUS:85133586573
SN - 1531-3433
VL - 26
SP - 693
EP - 699
JO - Current Pain and Headache Reports
JF - Current Pain and Headache Reports
IS - 9
ER -